Nautilus Biotechnology, Inc. logo

Nautilus Biotechnology, Inc. (NAUT) Q2 2024 Earnings

NAUT·Reported July 30, 2024·Before market open

Diluted EPS came in at $-0.14, beat the $-0.16 consensus by $0.02.

Diluted EPS
$-0.14beat by $0.02
Consensus: $-0.16
SEC

SEC Filings

Financial Snapshot

Trailing eight quarters through Q2 2024

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q2 2024 Earnings FAQ

Common questions about Nautilus Biotechnology, Inc.'s Q2 2024 earnings report.

Nautilus Biotechnology, Inc. (NAUT) reported Q2 2024 earnings on July 30, 2024 before market open.

Nautilus Biotechnology, Inc. reported diluted EPS of $-0.14 for Q2 2024.

EPS beat the consensus estimate of $-0.16 by $0.02.

You can read the 8-K earnings release (0001808805-24-000055) and the 10-Q periodic report (0001808805-24-000058) directly on SEC EDGAR. The filing index links above go to sec.gov.